These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7547360)

  • 1. Progress toward the development of a respiratory syncytial virus vaccine.
    Ewasyshyn M; Klein M
    Pediatr Pulmonol Suppl; 1995; 11():81-3. PubMed ID: 7547360
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective and disease-enhancing immune responses to respiratory syncytial virus.
    Anderson LJ; Heilman CA
    J Infect Dis; 1995 Jan; 171(1):1-7. PubMed ID: 7798649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for a respiratory syncytial virus vaccine.
    Hall CB
    Science; 1994 Sep; 265(5177):1393-4. PubMed ID: 7915433
    [No Abstract]   [Full Text] [Related]  

  • 4. [The status of research to develop new vaccines against infection caused by the respiratory syncytial virus].
    Pervikov IuV; Litvinov SK
    Vopr Virusol; 1988; 33(5):523-9. PubMed ID: 3064426
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology.
    de Waal L; Wyatt LS; Yüksel S; van Amerongen G; Moss B; Niesters HG; Osterhaus AD; de Swart RL
    Vaccine; 2004 Feb; 22(8):923-6. PubMed ID: 15161069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus--how soon will we have a vaccine?
    Toms GL
    Arch Dis Child; 1995 Jan; 72(1):1-3. PubMed ID: 7717728
    [No Abstract]   [Full Text] [Related]  

  • 7. Respiratory syncytial virus vaccine development.
    Kahn JS
    Curr Opin Pediatr; 2000 Jun; 12(3):257-62. PubMed ID: 10836163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis.
    Piedra PA; Grace S; Jewell A; Spinelli S; Bunting D; Hogerman DA; Malinoski F; Hiatt PW
    Pediatr Infect Dis J; 1996 Jan; 15(1):23-31. PubMed ID: 8684872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
    Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE
    Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In search of a vaccine for respiratory syncytial virus: the saga continues.
    Englund J
    J Infect Dis; 2005 Apr; 191(7):1036-9. PubMed ID: 15747236
    [No Abstract]   [Full Text] [Related]  

  • 11. Respiratory syncytial virus vaccines.
    Karron RA; Ambrosino DM
    Pediatr Infect Dis J; 1998 Oct; 17(10):919-20. PubMed ID: 9802636
    [No Abstract]   [Full Text] [Related]  

  • 12. Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccine.
    Welliver RC; Tristram DA; Batt K; Sun M; Hogerman D; Hildreth S
    J Infect Dis; 1994 Aug; 170(2):425-8. PubMed ID: 8035030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis.
    Piedra PA; Cron SG; Jewell A; Hamblett N; McBride R; Palacio MA; Ginsberg R; Oermann CM; Hiatt PW;
    Vaccine; 2003 Jun; 21(19-20):2448-60. PubMed ID: 12744878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with RSV M
    Fazolo T; Gassen RB; de Freitas DN; Borges TJ; Rigo MM; da Silva RD; Maito F; Cunha A; Gasparin Bueno Mendes DA; Báfica A; Vargas JE; de Souza APD; Bonorino C
    Antiviral Res; 2018 Sep; 157():102-110. PubMed ID: 29990516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular Immune Correlates Preventing Disease Against Respiratory Syncytial Virus by Vaccination with Virus-Like Nanoparticles Carrying Fusion Proteins.
    Lee YT; Ko EJ; Kim KH; Hwang HS; Lee Y; Kwon YM; Kim MC; Lee YN; Jung YJ; Kang SM
    J Biomed Nanotechnol; 2017 Jan; 13(1):84-98. PubMed ID: 29302248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do recombinant-engineered nanoparticle vaccines hold promise for the prevention of respiratory syncytial virus?
    Lee YT; Kwon YM; Kang SM
    Nanomedicine (Lond); 2016; 11(5):439-42. PubMed ID: 26893211
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenesis of respiratory syncytial virus vaccine-augmented pathology.
    Graham BS
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 2):S63-6. PubMed ID: 7551416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis.
    Piedra PA; Grace S; Jewell A; Spinelli S; Hogerman DA; Malinoski F; Hiatt PW
    Pediatr Infect Dis J; 1998 Mar; 17(3):217-24. PubMed ID: 9535249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory syncytial virus: back to basics.
    Glezen WP
    J Allergy Clin Immunol; 2009 Feb; 123(2):404-5. PubMed ID: 19121859
    [No Abstract]   [Full Text] [Related]  

  • 20. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines.
    Murphy BR; Hall SL; Kulkarni AB; Crowe JE; Collins PL; Connors M; Karron RA; Chanock RM
    Virus Res; 1994 Apr; 32(1):13-36. PubMed ID: 8030364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.